ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

Dispute At City of Hope Pits Center Against For-Profit Physician Group.

May 28, 2010

Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer

July 29, 2011

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

ASCO Issues RFP To Establish Washington Office

August 11, 1989

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010